CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine

Cell Death Differ. 2003 Mar;10(3):371-82. doi: 10.1038/sj.cdd.4401168.

Abstract

Apoptotic-cell clearance is dependent on several macrophage surface molecules, including CD14. Phosphatidylserine (PS) becomes externalised during apoptosis and participates in the clearance process through its ability to bind to a novel receptor, PS-R. CD14 has the proven ability to bind phospholipids and may function as an alternative receptor for the externalised PS of apoptotic cells. Here we demonstrate that CD14 does not function preferentially as a PS receptor in apoptotic-cell clearance. Compared with phosphatidylcholine and phosphatidylethanolamine, PS was the least active phospholipid binding to human monocyte-derived macrophages and showed no specificity for soluble or membrane-anchored CD14. Significantly, PS-containing liposomes failed to inhibit CD14-dependent uptake of apoptotic cells by macrophages. PS exposure was, however, found to be insufficient for either CD14-dependent or CD14-independent apoptotic-cell uptake by phagocytes. The additional features that enable apoptotic-cell clearance are derived from mechanisms that can be divorced temporally from those responsible for the morphological features of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Annexin A5 / pharmacology
  • Apoptosis*
  • Cell Line
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Erythrocytes / metabolism
  • Flow Cytometry
  • Humans
  • Leukocytes / metabolism
  • Ligands
  • Lipid Metabolism
  • Lipopolysaccharide Receptors / metabolism
  • Lipopolysaccharide Receptors / physiology*
  • Liposomes / metabolism
  • Macrophages / metabolism*
  • Monocytes / metabolism
  • Neutrophils / metabolism
  • Phagocytosis
  • Phosphatidylserines / metabolism*
  • Protein Binding
  • Protein Synthesis Inhibitors / pharmacology
  • Recombinant Proteins / metabolism
  • Time Factors
  • Ultraviolet Rays

Substances

  • Annexin A5
  • Ligands
  • Lipopolysaccharide Receptors
  • Liposomes
  • Phosphatidylserines
  • Protein Synthesis Inhibitors
  • Recombinant Proteins
  • Cycloheximide